A new combination drug treatment has shown promising results in patients with pan-refractory, recurrent/metastatic head and neck cancer, according to a study published today in the Journal of Clinical Oncology.
Mar 28, 2023
0
2
Brienne Miner, MD, MHS, assistant professor of medicine (geriatrics), loves to talk about sleep. She first became interested in the subject when she noticed the prevalence of sleep problems among her older patients, and the ...
Mar 28, 2023
0
16
Providing an overview of the submissions process and examples of U.S. Food and Drug Administration (FDA) applications for Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD), a new article can help ...
Mar 27, 2023
0
2
Many cancer patients undergo treatment with multiple drugs, each of which attacks cancer in a different way, so the combination fights cancer on many fronts. But more drugs mean higher risks of side effects.
Mar 23, 2023
0
18
A team of researchers at the Keck School of Medicine of USC have found a drug with the potential for curbing painful hyperinflammation from osteoarthritis, according to results of an animal study.
Mar 22, 2023
0
836
Abemaciclib (Verzenio) with endocrine therapy (tamoxifen or an aromatase inhibitor) is now approved for the adjuvant treatment of adult patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, ...
Mar 10, 2023
0
1
Congenital diaphragmatic hernia (CDH) is a common condition, affecting one in every 2,500 births. Up to 30% of affected babies die from it. The main problem is underdeveloped lungs. The condition also involves a hole in the ...
Mar 9, 2023
0
27
Patients with pulmonary arterial hypertension (high blood pressure in the arteries that supply the lungs, also called PAH) had approximately double the reduction in pulmonary vascular resistance (PVR) if they took the PAH ...
Mar 7, 2023
0
1
You toss, you turn, you can't fall asleep.
Mar 6, 2023
0
4
A new mathematical model which aims to optimize treatment for prostate cancer has been developed by experts at the University of Portsmouth.
Mar 1, 2023
0
1
